Product Images Ezetimibe And Simvastatin

Ezetimibe and Simvastatin Tablets are a prescription medication containing 10 mg ezetimibe and 10 mg simvastatin per tablet. The usual dosage for this medication can be found in the package insert. It should be stored at a temperature of 20° to 25°C (68° to 77°F) and kept in a tightly closed container, out of the reach of children. This medication is manufactured by Dr. Reddy's Laboratories LA LLC in Shreveport, LA 71106 USA and is distributed by Dr. Reddy's Laboratories Inc. 150072953-00 in Princeton, NJ 08540 USA. Its NDC is 43598-742-90.*

This is a description for a medicine called "Ezetimibe and Simvastatin Tablets". Each tablet contains 10 mg of ezetimibe and 20 mg of simvastatin. It is recommended to see the package insert for full prescribing information. It should be stored at 20°C to 25°C and kept out of the reach of children. The medicine is manufactured by Dr. Reddy's Laboratories LA LLC in Shreveport, LA and distributed by Dr. Reddy's Laboratories Inc. in Princeton, NJ. The NDC and GTIN codes are provided. The document also includes an image of the packaging.*

This is a medication containing 10mg of ezetimibe and 40mg of simvastatin per tablet. The usual dosage should be consulted through package insert. It should be stored between 20°C to 25°C in a tightly closed, light-resistant container. The tablets need to have a child-resistant closure. This medication should be kept away from children. Manufactured by Dr. Reddy's Laboratories LA LLC and distributed by Dr. Reddy's Laboratories Inc. The expiration date for this medication is 05/18 with NDC 43598-743-90.*

Ezetimibe and Simvastatin Tablets are a pharmaceutical product that comes in a container of 90 tablets. The dosage for the medication is specified in the package insert. It is essential to store the tablets in a tightly sealed container, away from children, at a temperature of 20°C to 25°C (68°F to 77°F). The product is manufactured and distributed by Dr. Reddy's Laboratories Inc. in the United States.*

The table shows the percentage of patients who experienced major vascular events while taking either a placebo or Ezetimibe and Simvastatin combination drug. The events were tracked for several years, and the number of patients still being monitored is also shown.*